Trial Profile
Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2022
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Cerebrovascular disorders
- Focus Proof of concept; Therapeutic Use
- Acronyms PASTIS
- 04 Aug 2022 Primary endpoint (Change in local cerebral blood flow within deep brain nuclei and deep white matter) has not been met, according to Results presented at the Alzheimer's Association International Conference 2022.
- 04 Aug 2022 Results presented at the Alzheimer's Association International Conference 2022
- 08 Feb 2019 Status changed from active, no longer recruiting to completed.